A recent UArizona College of Pharmacy study suggests that personal genomic educational testing (PGET), which is thought to have potential as a learning tool in pharmacogenomic education, may offer no significant benefits in terms of improved knowledge or attitudes for PharmD students towards the subject. The results of the study have important implications for the implementation of PGET in PharmD programs in light of the high cost of genotyping and the potential ethical, legal, and regulatory issues around genotyping of students.
Related